Edition:
United States

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

10.96HKD
9:23pm EST
Change (% chg)

HK$-0.34 (-3.01%)
Prev Close
HK$11.30
Open
HK$11.20
Day's High
HK$11.30
Day's Low
HK$10.96
Volume
6,533,000
Avg. Vol
17,373,390
52-wk High
HK$11.86
52-wk Low
HK$5.22

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln
Thursday, 9 Nov 2017 05:10am EST 

Nov 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK> ::9-month ‍revenue RMB11,446.73 million, up 9.5​ percent.‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​.9-month net profit attributable to owners RMB1.80​ billion versus RMB1.30 billion.  Full Article

Sino Biopharmaceutical posts HY revenue of about RMB7,482.86 mln
Monday, 21 Aug 2017 06:19am EDT 

Aug 21 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>:HY revenue was approximately RMB7,482.86 million, an increase of approximately 10.6 percent.Board of directors of company declared payment of a second quarterly dividend of HK2 cents per share.Before accounting for unrealized fair value gains & losses of equity investments & financial assets, HY net profit about RMB1,076.34 million.  Full Article

Sino Biopharmaceutical says qtrly net profit RMB 579 million
Friday, 26 May 2017 05:56am EDT 

May 26 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::Qtrly revenue was approximately RMB3,863.21 million, an increase of approximately 10.1% over same period last year.Qtrly net profit RMB 579 million versus RMB 427.6 million.Declared payment of a first quarterly dividend of HK1.5 cents per share for three months ended 31 March, 2017.  Full Article

Sino Biopharmaceutical appoints Cheng Cheung Ling as executive director, vice chairlady
Monday, 10 Apr 2017 10:01am EDT 

Sino Biopharmaceutical Ltd <1177.HK> :Cheng Cheung Ling has been appointed as an executive director, vice chairlady of board.  Full Article

Sino Biopharmaceutical FY profit attributable HK$1.91 bln
Monday, 13 Mar 2017 10:52am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: FY profit attributable to equity holders HK$1.91 billion, 7.6% higher . FY revenue HK$ 15.83 billion versus HK$14.55 billion .Company recommended payment of a final dividend of HK1.5 cents per share for year ended 31 December, 2016.  Full Article

Sino Biopharmaceutical nine-month net profit HK$1.56 bln
Friday, 18 Nov 2016 04:28am EST 

Sino Biopharmaceutical Ltd <1177.HK> : Declared payment of third quarterly dividend of HK1.5 cents per share for three months ended 30 september, 2016 . 9-mnth net profit HK$1.56 billion versus HK$1.39 billion . 9-month revenue HK$12.33 billion compared to HK$11.44 billion a year ago . Pharmaceutical industry in particular also must face operating challenges caused by ongoing reform in public hospitals . Profit in pharmaceutical industry may also be affected as a result of quality consistency assessment of generic drugs ."Expects a general positive development trend in pharmaceutical industry regardless of adjustment pressure in coming quarter".  Full Article

Sino biopharmaceutical enters into a facility agreement
Wednesday, 28 Sep 2016 05:11am EDT 

Sino Biopharmaceutical Ltd <1177.HK> : Loan facility in an aggregate principal amount of US$300 million . Company, as borrower, entered into a facility agreement with original lenders . Original lenders have agreed to make available to company a dual tranche three-year term loan facility .Amount borrowed under loan facility will be used by company for refinancing of existing loans owed by company.  Full Article

Sino Biopharmaceutical says there was fire in treatment plant at Lianyungang<1177.HK>
Thursday, 1 Sep 2016 10:26am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: On 27 August 2016, there was a fire in an used waste solvent treatment plant at Lianyungang, PRC . Accident did not extend to production plants and the subsidiary has resumed full production . Expects the incident does not have any material impact on the group's general operation, financial position and cash flows. . There were damages to certain properties and facilities of the subsidiary .  Full Article

Sino Biopharmaceutical HY net profit of hk$1.01 bln versus hk$928.2 mln a year ago<1177.HK>
Friday, 26 Aug 2016 05:01am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: Interim results announcement for the six months ended 30 June, 2016 <1177.HK> . HY net profit of hk$1.01 billion versus hk$928.2 million a year ago . HY revenue was approximately hk$8.04 billion, an increase of approximately 8.0% . Declared payment of a second quarterly dividend of hk1.5 cents per share for three months ended 30 June . Believes the pharmaceutical industry will develop as a whole in a healthier and more standardized manner" .  Full Article

Sino Biopharmaceutical appoints Tse Ping as CEO<1177.HK>
Friday, 29 Jul 2016 04:32am EDT 

Sino Biopharmaceutical Ltd <1177.HK>: Resignation of executive director and change of chief executive officer <1177.HK> . Tse Ping, an executive director of the company, has been appointed as the Chief Executive Officer of the company . Says Xu Xiaoyang tendered his resignation as executive director,and Chief Executive Officer .  Full Article

BRIEF-Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln

* ‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​